Embedded Software Engineer
About the job
- A Bachelor's or master's degree in Computer Engineering or a related field is required.
- Three to five years of relevant industry work experience is required.
- Formal software documentation experience is required, preferably in medical device development.
- Direct experience with C/C++ and Python is required.
- Ability to work in a Linux environment is required.
- Experience with Git or other code repository systems is required.
- A solid foundation in the TCP/IP protocol stack is required.
- Understanding of multithreading and real-time systems is required.
- Experience with PID-based control for motion and temperature control is required.
- Knowledge of hardware communication interfaces such as Ethernet, Serial, SPI, and I2C is required.
- Familiarity with industrial communication protocols such as MODBUS is required.
- Interfacing experience with Clinical Lab Information Systems is required.
- Histology laboratory workflow experience is required.
- Experience building vision systems for process and quality control is required.
- Experience with data security and HIPAA requirements is required.
- Strong interpersonal, verbal, and written communication skills are required.
- Time management skills to prioritize and meet deadlines are required.
- Ability to work independently and as a member of a team is required.
- Flexibility to work in a changing and fast-paced environment is required.
- Ability to meet aggressive milestones and deadlines is required.
- Develop software for medical devices within a well-established robotics framework.
- Develop drivers to interface with motor controllers, cameras, scanners, and programmable logic controller systems.
- Develop algorithms to control a multicomponent mechatronic system based on software requirements.
- Write software design and software test documents.
- Perform unit testing.
- Collaborate with mechanical, electrical, and optics engineering groups to gather software requirements.
- Provide software tools to streamline product development.
- Experience working with robotics platforms such as ROS or YARP is a plus.
About the company
Clarapath offers automated pathology solutions through its SectionStar robotic device, which consolidates nine microtomy steps into a single platform to improve slide quality, speed, and cost. It also operates a CLIA-certified contract laboratory providing Routine Histology, Whole Slide Imaging, Quantitative Image Analysis, and Data Hosting Management for hospitals, research institutions, and pharmaceutical companies. The SectionStar reduces manual labor and variability by automating the workflow, while lab services can be accessed on a contract basis. Clarapath aims to streamline pathology workflows, shorten turnaround times, and cut costs by delivering end-to-end automation and analytics across hardware and lab services.
Company Size
51-200
Company Stage
Series B
Total Funding
$75.3M
Headquarters
Town of Mount Pleasant, New York
Founded
2014
Get referred to Clarapath
See people who can refer or advise you
Simplify's Take
What believers are saying
- March 2026 SectionStar installations started at select U.S. sites, validating commercial adoption.
- May 2026 TrimStar Pro lowers entry cost for cash-constrained histology labs.
- Northwell Ventures, Mayo Clinic, and Ochsner Ventures backed the $36 million July 2024 round.
What critics are saying
- Danaher’s Leica Biosystems and Sakura Finetek keep shipping broader pathology workflow suites in 2026.
- SectionStar remains FDA-registered, not FDA-cleared, limiting clinical credibility versus regulated competitors.
- Clarapath’s small workforce, roughly 78 employees in March 2026, strains sales and service scaling.
What makes Clarapath unique
- May 2026 TrimStar Pro gives Clarapath a modular on-ramp to SectionStar.
- March 2026 SectionStar release adds improved reliability, serviceability, and workflow options.
- Clarapath manufactures both systems in White Plains, New York, under ISO 13485.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Vision Insurance
Dental Insurance
Life Insurance
Paid Vacation
Paid Holidays
Growth & Insights and Company News
6 month growth
-1%1 year growth
0%2 year growth
3%Clarapath Closes $36M Series B round to transform 150-year old laboratory processes.
Clarapath, a healthcare robotic microtomy systems provider, has launched TrimStar Pro™, an FDA-registered facing and trimming solution for histology laboratories. The system addresses block facing and trimming, one of histology's most labour-intensive processes, whilst complementing the company's flagship SectionStar® product. TrimStar Pro™ features a compact footprint approximately half the size of SectionStar® and supports multiple operational modes to accommodate varying laboratory workflows. The system is designed as a modular, upgradeable platform allowing laboratories to begin automation and later progress to full SectionStar capabilities. Clarapath designs, manufactures and assembles its automated microtomy systems entirely in the United States at its ISO 13485-certified New York facility. Both TrimStar Pro™ and SectionStar™ are available to qualifying customers in the US and select international locations.
Clarapath reinforces leadership in healthcare robotic microtomy systems with launch of TrimStar Pro(TM). PR Newswire Yesterday at 11:23am PDT New FDA-registered facing and trimming solution is designed for labs that want meaningful throughput gains now. WHITE PLAINS, N.Y., May 4, 2026 /PRNewswire/ - Clarapath, a leader in healthcare robotic microtomy systems, announced the launch of TrimStar Pro(TM), a purpose-built facing and trimming solution designed to help histology laboratories take a strategic first step toward automation with greater flexibility and lower capital investment. As laboratories face increasing pressure to improve efficiency, consistency, and turnaround times, many are seeking practical ways to begin automating key processes. TrimStar Pro(TM) will address this need by focusing on one of the most labor-intensive steps in histology of block facing and trimming while also complementing Clarapath's flagship SectionStar(R) product. "SectionStar(R) sets the benchmark for full automation in histology, and TrimStar(TM) Pro is the natural extension of that vision," said Eric Feinstein, CEO. "We've designed a modular, upgradeable platform that allows labs to start with TrimStar Pro(TM) and seamlessly progress to SectionStar when ready. It's a true on-ramp to full automation - without compromising integration, data integrity, or long-term scalability." Engineered for performance and flexibility, TrimStar Pro(TM) delivers advanced capabilities in a compact footprint that is approximately half the size of the full SectionStar(R) system. The system supports multiple modes of operation to accommodate varying lab preferences and workflows, while advanced sensing capabilities help ensure consistent and precise block preparation. TrimStar Pro(TM) enhances efficiency and repeatability, all while aligning seamlessly with existing laboratory processes. Clarapath is the only provider in this category to design, manufacture, and assemble its automated microtomy systems entirely in the United States. Like SectionStar(TM), TrimStar Pro(TM) is built in Clarapath's ISO 13485-certified facility in New York, with all service and support handled directly by its U.S. based team. With the introduction of this new device Clarapath expands its portfolio to deliver a complete, scalable automation pathway enabling laboratories to adopt robotic microtomy on their terms while maintaining a clear path to the industry's most advanced solution. Both systems are currently FDA-registered and available for purchase to qualifying customers in the U.S. and certain international locations. Contact its sales team at [email protected] to learn more. About Clarapath Clarapath is a medical robotics company based in Westchester County, NY. Their mission is to transform and modernize laboratory workflows with the goal of improving patient care, decreasing costs, and enhancing the quality and consistency of laboratory processes. SectionStar(TM) and TrimStar Pro(TM) by Clarapath are ground-breaking electro-mechanical systems designed to elevate and automate histology workflows and provide pathologists with the tissue samples they need to make the most accurate diagnoses. Through the use of innovative technology, data, and precision analytics, Clarapath is paving the way for a new era of laboratory medicine. Learn more at Clarapath.com SOURCE Clarapath This is a paid placement. For further inquiries, please contact PR Newswire directly.
Clarapath, a White Plains-based medical robotics company, has launched the latest version of its SectionStar robotic microtomy platform for clinical histology laboratories. The FDA-registered system is designed to automate tissue sectioning whilst addressing increasing case volumes and staffing pressures. The updated platform features improved sectioning consistency and reliability, enhanced software and user interface, greater system robustness for high-throughput environments, and expanded workflow options. Developed in collaboration with histotechnologists and pathology laboratories, SectionStar aims to standardise tissue sectioning whilst allowing skilled staff to focus on higher-value work. The system is currently being deployed at select sites across the US. Clarapath will showcase its products at the USCAP 115th Annual Meeting in San Antonio this March.
Clarapath, a medical robotics company based in White Plains, NY, raised $36 million in Series B-1 funding. The round was led by Northwell Ventures with participation from CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures. The funds will be used to accelerate the commercialization of SectionStar™, expand sales and service, enhance precision manufacturing, and continue R&D. The company is led by CEO Eric Feinstein and operates a CLIA-certified lab in Hawthorne, NY.